Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook

By: via Benzinga
Vamil Divan of Credit Suisse offered his 2016 outlook for large-cap U.S. pharmaceuticals. Divan noted that sector-wide ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.